Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Real World Study of Yangxuenao Granules Reducing Bleeding Risk in Patients With Acute Ischemic Stroke Treated With Intravenous Thrombolysis

NCT04949906 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.

NCT NCT04949906
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04949906 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Real World Study of Yangxuenao Granules Reducing Bleeding Risk in Patients With Acute Ischemic Stroke Treated With Intravenous Thrombolysis
Lead sponsor
Peking University Third Hospital
Phase
Observational
Overall status
Completed
Start date
June 1, 2019
Completion date
November 1, 2020
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral infarction